Literature DB >> 30419502

The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand?

Antonino Uncini1, Satoshi Kuwabara2.   

Abstract

It is controversial as to whether the electrophysiological Guillain-Barré syndrome (GBS) subtypes can be diagnosed on the basis of a single study and which criteria sets and cut-offs should be used. Serial electrophysiologic studies have shown that a significant number of patients changed electrodiagnostic subtype largely because of the recognition of reversible conduction failure as a possible evidence of axonal pathology. However, other reports concluded that electrodiagnosis can be made by a single study, the subtypes depending on the characteristic of the criteria set applied. Such divergent views, although explicable by the different methodology employed, can be confusing in the everyday practice. We argue that the pathophysiology of GBS is dynamic and that serial studies allow a more accurate diagnosis of subtypes. A second study, although not always practicable, is recommended in patients showing no clear demyelinating features, low amplitude distal compound muscle action potentials or conduction block without temporal dispersion. For practical purposes, we propose that at a first study Uncini's or Rajabally's criteria sets can be employed for an indicative subtype diagnosis. Finally, although the GBS subtype diagnosis has currently no impact on treatment, we believe that is important for understanding the underlying pathophysiology and prognostication.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Acute inflammatory demyelinating polyradiculoneuropathy; Axonal Guillain-Barré syndrome; Electrodiagnostic criteria; Guillain-Barré syndrome; Reversible conduction failure; Serial electrophysiological studies

Mesh:

Year:  2018        PMID: 30419502     DOI: 10.1016/j.clinph.2018.09.025

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  15 in total

Review 1.  Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis.

Authors:  Vishakha Singh; Prince Allawadhi; Amit Khurana; Anil Kumar Banothu; Kala Kumar Bharani
Journal:  Sens Int       Date:  2021-05-13

2.  Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barré syndrome-a case report.

Authors:  S Coniglio; G Turchi; G Giovannini; M Mazzoli; S Meletti; Anna Elisabetta Vaudano
Journal:  Neurol Sci       Date:  2022-04-07       Impact factor: 3.307

3.  [Association of motor nerve conduction block with different subtypes of childhood Guillain-Barré syndrome].

Authors:  Rui-Di Sun; Jun Jiang; Zhi-Sheng Liu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

4.  Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.

Authors:  Velina Nedkova; Gerardo Gutiérrez-Gutiérrez; Francisco J Navacerrada-Barrero; José Berciano; Carlos Casasnovas
Journal:  Acta Neurol Belg       Date:  2021-02-18       Impact factor: 2.396

Review 5.  Diagnosis and management of Guillain-Barré syndrome in ten steps.

Authors:  Sonja E Leonhard; Melissa R Mandarakas; Francisco A A Gondim; Kathleen Bateman; Maria L B Ferreira; David R Cornblath; Pieter A van Doorn; Mario E Dourado; Richard A C Hughes; Badrul Islam; Susumu Kusunoki; Carlos A Pardo; Ricardo Reisin; James J Sejvar; Nortina Shahrizaila; Cristiane Soares; Thirugnanam Umapathi; Yuzhong Wang; Eppie M Yiu; Hugh J Willison; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2019-09-20       Impact factor: 42.937

6.  Case Report: Acute Bulbar Palsy Plus Syndrome: A Guillain-Barré Syndrome Variant More Prone to Be a Subtype Than Overlap of Distinct Subtypes.

Authors:  Qian Cao; Hong Chu; Xiujuan Fu; Jiajia Yao; Zheman Xiao; Zuneng Lu
Journal:  Front Neurol       Date:  2020-11-24       Impact factor: 4.003

7.  Guillain-Barré syndrome following COVID-19: new infection, old complication?

Authors:  Marina Padroni; Vincenzo Mastrangelo; Gian Maria Asioli; Lucia Pavolucci; Samir Abu-Rumeileh; Maria Grazia Piscaglia; Pietro Querzani; Claudio Callegarini; Matteo Foschi
Journal:  J Neurol       Date:  2020-04-24       Impact factor: 4.849

8.  Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study.

Authors:  José Berciano; Pedro Orizaola; Elena Gallardo; Ana L Pelayo-Negro; Pascual Sánchez-Juan; Jon Infante; María J Sedano
Journal:  Clin Neurophysiol Pract       Date:  2019-11-30

9.  Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.

Authors:  Samir Abu-Rumeileh; Ahmed Abdelhak; Matteo Foschi; Hayrettin Tumani; Markus Otto
Journal:  J Neurol       Date:  2020-08-25       Impact factor: 4.849

10.  Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review.

Authors:  P De Sanctis; P E Doneddu; L Viganò; C Selmi; E Nobile-Orazio
Journal:  Eur J Neurol       Date:  2020-09-11       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.